18 December 2020
Heart Valve Voice is pleased to announce that former Clinical Director for Heart Disease for NHS England, Professor Huon Gray, has joined our team in an advisory role and has agreed to act as Chair of the new Heart Valve Voice Clinical Advisory Panel.
19 November 2020
The first wave of COVID-19 placed huge pressure on our health service, with elective surgeries suspended, and treatment capacity reduced significantly. We spoke to Consultant Cardiologist Dr Michael Mullen from Barts, London to understand how his centre responded to the crisis, how the pathway has changed and what they did to maximise treatment capacity.
16 October 2020
Heart Valve Voice’s Gold Standard sets out specific recommendations for multidisciplinary teams (MDTs). One of the impacts of COVID-19 has been the move from in-person MDT's to a virtual format. These new virtual MDTs are a step in the right direction, as this more agile approach will allow for faster decision making, and with more input from external services.
14 July 2020
In 2018 we released Our Gold Standard of Care - Best Practice in the Diagnosis, Treatment and Management of Heart Valve Disease. Our Gold Standard brought together leading clinicians from across the treatment pathway, as well as a group of heart valve disease patients, to identify what best practice in heart valve disease care looks like. This gold standard is set out in a series of Quality Statements and Recommendations which cover the treatment pathway in its entirety.
13 July 2020
President of the British Cardiovascular Society, Professor Simon Ray, recently recorded a podcast with the British Medical Journal on ‘The Future of Cardiology in the Post-COVID-19 era', where he discussed how digital innovation is changing the cardiovascular landscape. Professor Ray took some time to talk to our CEO Wil Woan about virtual valve clinics, digital consultations, virtual MDTs, and how digital innovation will change the future of valve disease care.
29 June 2020
Last week NICE (National Institute for Health and Care Excellence), the body which provides evidence-based recommendations for care and service provision in England, announced that they had restarted publishing non-COVID-19 guidance in a phased manner. Unfortunately, heart valve disease was not included as a priority in the first phase of guidelines. This means that these guidelines will be delayed until late this year at the very earliest, four years after NHS England first called for the guidelines.
18 May 2020
In the last few days, we have seen discussions amongst valve disease patients online regarding hospitals use of Anticipatory Care Planning. In these discussions, there has been some concern about hospitals including Do Not Resuscitate (DNR) orders within a valve disease patients ACP.
07 May 2020
On April 16th we released a statement which mapped out our response to the impact of the Covid-19 outbreak on cardiovascular disease, and we believe that now is the right time for us to begin to look forward and map a strategic direction for the next phase of our response.
16 April 2020
The global COVID-19 crisis has put an enormous strain on the UK health system which faces the battle of limiting the spread of Coronavirus whilst also providing the treatment and care that will save lives. As a result of this, the UK healthcare system is having to change the way it works and what they prioritise, impacting patients presenting with many conditions, including heart valve disease.